Altria reports third-quarter results and expands share repurchase program
On October 29, 2026, Altria Group, Inc. reported financial results for the quarter ended September 30, 2026. Revenue was $6.1 billion, and diluted earnings per share (EPS) were $1.51. The board of directors approved a $1 billion increase to the existing share repurchase program.
Key points
- In the third quarter of 2026, Altria reported $6.1 billion in revenue.
- In the oral tobacco products segment, operating income before general corporate expenses and amortization of intangibles (OCI) decreased 5.4% due to lower shipment volumes, higher costs, and increased promotional investments.
Financial results and share repurchases
In the third quarter of 2026, Altria reported $6.1 billion in revenue. Diluted earnings per share (EPS) grew 7.1% year-over-year. The company repurchased 5.9 million shares for a total of $400 million during the quarter.
The board of directors approved the $1 billion expansion of the share repurchase program on October 28, 2026, as part of its capital return strategy for shareholders.
Revenue by quarter, $B
Sector context: 18 covered companies in Consumer Staples reported a median revenue change of +5.4% YoY in their latest filings.
Operational risks and regulatory changes
In the oral tobacco products segment, operating income before general corporate expenses and amortization of intangibles (OCI) decreased 5.4% due to lower shipment volumes, higher costs, and increased promotional investments. New California legislation banning the manufacture and import of single-use e-vapor products starting in January 2027, and their retail sale from January 2028, adds further uncertainty.
The company is also involved in litigation regarding delays in issuing marketing orders for new tobacco products (PMTAs), creating uncertainty about future regulatory pathways for these products.
What to watch
Investors should monitor future company reports on shares outstanding to gauge the actual execution of the repurchase program. Tracking OCI in the oral tobacco products segment is also important to see if the company can stabilize profitability there.
Original sources
- 8-K EX-99.1 filing, October 29, 2026
- 8-K filing, October 29, 2026
- 10-Q risk factors compared with the 10-Q filing, July 30, 2026
- financial data (XBRL)
Cite this article
The fingerprint identifies the exact version of each original that the article was written from; the original stays at its source.
Follow Altria
A notification in your browser or on your phone when we publish about Altria. Free, no email, no account, no app.
Prepared by AI from official company documents; automatic checks and an AI editor review it before publication, and not every article is read by a person. This is not investment advice. Editorial standards
